Target intelligence / Profile preview

Pyruvate dehydrogenase kinase 1 pseudogene 2 (PDK1P2)

Target
PDK1P2
Molecular classification
Other, Pseudogene, Long non-coding RNA (lncRNA)
01

Overview

PDK1 pseudogene 2 (PDK1P2) is a non-coding pseudogene related to Pyruvate dehydrogenase kinase 1 (PDK1). Pseudogenes are generally non-functional copies of ancestral genes that may be transcribed as RNA but do not code for functional proteins due to mutations, frameshifts, or premature stop codons[5]. PDK1P2 has sequence similarity to the functional PDK1 gene but lacks protein-coding capacity. Some recent research has identified PDK1P2 (also referred to as lncRNA-PDPK2P) as a long non-coding RNA capable of acting as a competitive endogenous RNA, thereby indirectly regulating PDK1 levels and, subsequently, cellular processes such as proliferation and apoptosis in cancers like hepatocellular carcinoma[1]. However, PDK1P2 itself is not a therapeutic drug target, receptor, enzyme, or signaling protein, but may have an ancillary regulatory function on its functional counterpart.[1][5] If your inquiry pertains to druggable or therapeutically relevant protein targets, the correct entry would be "Pyruvate dehydrogenase kinase 1 (PDK1)" rather than the pseudogene PDK1P2.

Other names
Pyruvate dehydrogenase kinase 1 pseudogene 2Pyruvate dehydrogenase kinase, isozyme 1 pseudogenePDPK2PlncRNA-PDPK2P
02

Biological functions

OtherRegulation of parental gene (PDK1) expression via non-coding RNA mechanisms
03

Disease associations

OtherPotential regulatory role in cancer through modulation of PDK1 expression (e.g., hepatocellular carcinoma)
04

Biomarkers

Possible non-coding RNA biomarker for cancer progression in certain contexts, especially if used in conjunction with functional PDK1 expression

Beyond the preview

Go deeper on Pyruvate dehydrogenase kinase 1 pseudogene 2 (PDK1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate dehydrogenase kinase 1 pseudogene 2 (PDK1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call